Working Group on Functional Outcome Measures for Clinical Trials, ., Bhasin, S., Espeland, M. A., Evans, W. J., Ferrucci, L., Fried, L. P., … Parks, M. (2009). Indications, labeling, and outcomes assessment for drugs aimed at improving functional status in older persons: a conversation between aging researchers and FDA regulators. J Gerontol A Biol Sci Med Sci, 64(4), 487–491. https://doi.org/10.1093/gerona/gln042

Working Group on Functional Outcome Measures for Clinical Trials, Mary, Shalender Bhasin, Mark A. Espeland, William J. Evans, Luigi Ferrucci, Linda P. Fried, Thomas M. Gill, et al. “Indications, labeling, and outcomes assessment for drugs aimed at improving functional status in older persons: a conversation between aging researchers and FDA regulators.” J Gerontol A Biol Sci Med Sci 64, no. 4 (April 2009): 487–91. https://doi.org/10.1093/gerona/gln042.

Working Group on Functional Outcome Measures for Clinical Trials, Bhasin S, Espeland MA, Evans WJ, Ferrucci L, Fried LP, et al. Indications, labeling, and outcomes assessment for drugs aimed at improving functional status in older persons: a conversation between aging researchers and FDA regulators. J Gerontol A Biol Sci Med Sci. 2009 Apr;64(4):487–91.

Working Group on Functional Outcome Measures for Clinical Trials, Mary, et al. “Indications, labeling, and outcomes assessment for drugs aimed at improving functional status in older persons: a conversation between aging researchers and FDA regulators.” J Gerontol A Biol Sci Med Sci, vol. 64, no. 4, Apr. 2009, pp. 487–91. Pubmed, doi:10.1093/gerona/gln042.

Working Group on Functional Outcome Measures for Clinical Trials, Bhasin S, Espeland MA, Evans WJ, Ferrucci L, Fried LP, Gill TM, Pahor M, Studenski S, Guralnik J, Nayfield S, Romashkin S, Perlstein R, Burke L, Parks M. Indications, labeling, and outcomes assessment for drugs aimed at improving functional status in older persons: a conversation between aging researchers and FDA regulators. J Gerontol A Biol Sci Med Sci. 2009 Apr;64(4):487–491.